<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37614232</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>25</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>28</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sj&#xf6;gren's syndrome based on integrated bioinformatics and single-cell RNA-seq analysis.</ArticleTitle><Pagination><StartPage>1212330</StartPage><MedlinePgn>1212330</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1212330</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1212330</ELocationID><Abstract><AbstractText Label="BACKGROUND">Systemic lupus erythematosus (SLE) and primary Sj&#xf6;gren's syndrome (pSS) are common systemic autoimmune diseases that share a wide range of clinical manifestations and serological features. This study investigates genes, signaling pathways, and transcription factors (TFs) shared between SLE and pSS.</AbstractText><AbstractText Label="METHODS">Gene expression profiles of SLE and pSS were obtained from the Gene Expression Omnibus (GEO). Weighted gene co-expression network analysis (WGCNA) and differentially expressed gene (DEG) analysis were conducted to identify shared genes related to SLE and pSS. Overlapping genes were then subject to Gene Ontology (GO) and protein-protein interaction (PPI) network analyses. Cytoscape plugins cytoHubba and iRegulon were subsequently used to screen shared hub genes and predict TFs. In addition, gene set variation analysis (GSVA) and CIBERSORTx were used to calculate the correlations between hub genes and immune cells as well as related pathways. To confirm these results, hub genes and TFs were verified in microarray and single-cell RNA sequencing (scRNA-seq) datasets.</AbstractText><AbstractText Label="RESULTS">Following WGCNA and limma analysis, 152 shared genes were identified. These genes were involved in interferon (IFN) response and cytokine-mediated signaling pathway. Moreover, we screened six shared genes, namely <i>IFI44L, ISG15, IFIT1, USP18, RSAD2</i> and <i>ITGB2</i>, out of which three genes, namely <i>IFI44L, ISG15</i> and <i>ITGB2</i> were found to be highly expressed in both microarray and scRNA-seq datasets. IFN response and ITGB2 signaling pathway were identified as potentially relevant pathways. In addition, STAT1 and IRF7 were identified as common TFs in both diseases.</AbstractText><AbstractText Label="CONCLUSION">This study revealed <i>IFI44L, ISG15</i> and <i>ITGB2</i> as the shared genes and identified STAT1 and IRF7 as the common TFs of SLE and pSS. Notably, the IFN response and ITGB2 signaling pathway played vital roles in both diseases. Our study revealed common pathogenetic characteristics of SLE and pSS. The particular roles of these pivotal genes and mutually overlapping pathways may provide a basis for further mechanistic research.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Cui, Zhang, Wang, Gong, Al-Ward, Deng, Fan, Wang, Zhu and Sun.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yanling</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Huina</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zhen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gong</LastName><ForeName>Bangdong</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Tongji Hospital of Tongji University School of Medicine, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Ward</LastName><ForeName>Hisham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Yaxuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Orion</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Junbang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Wenmin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Yi Eve</ForeName><Initials>YE</Initials><AffiliationInfo><Affiliation>Stem Cell Translational Research Center, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Shanghai Institute of Stem Cell Research and Clinical Translation, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018821">CD18 Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C485560">USP18 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D043222">Ubiquitin Thiolesterase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092386" MajorTopicYN="N">Single-Cell Gene Expression Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012859" MajorTopicYN="Y">Sjogren's Syndrome</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005807" MajorTopicYN="N">Genes, Overlapping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018821" MajorTopicYN="N">CD18 Antigens</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D043222" MajorTopicYN="N">Ubiquitin Thiolesterase</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TFs</Keyword><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">hub genes</Keyword><Keyword MajorTopicYN="N">primary Sj&#xf6;gren&#x2019;s syndrome</Keyword><Keyword MajorTopicYN="N">scRNA-seq</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>24</Day><Hour>3</Hour><Minute>55</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37614232</ArticleId><ArticleId IdType="pmc">PMC10442653</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1212330</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Imgenberg-Kreuz J, Almlof JC, Leonard D, Sjowall C, Syvanen AC, Ronnblom L, et al. . Shared and unique patterns of DNA methylation in systemic lupus erythematosus and primary Sjogren&#x2019;s syndrome. Front Immunol (2019) 10:1686. doi:&#xa0;10.3389/fimmu.2019.01686</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01686</ArticleId><ArticleId IdType="pmc">PMC6688520</ArticleId><ArticleId IdType="pubmed">31428085</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin-Gutierrez L, Peng J, Thompson NL, Robinson GA, Naja M, Peckham H, et al. . Stratification of patients with Sjogren&#x2019;s syndrome and patients with systemic lupus erythematosus according to two shared immune cell signatures, with potential therapeutic implications. Arthritis Rheumatol (2021) 73(9):1626&#x2013;37. doi:&#xa0;10.1002/art.41708</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.41708</ArticleId><ArticleId IdType="pubmed">33645922</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldblatt F, O&#x2019;Neill SG. Clinical aspects of autoimmune rheumatic diseases. Lancet (2013) 382(9894):797&#x2013;808. doi:&#xa0;10.1016/S0140-6736(13)61499-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(13)61499-3</ArticleId><ArticleId IdType="pubmed">23993190</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasoto SG, Adriano de Oliveira Martins V, Bonfa E. Sjogren&#x2019;s syndrome and systemic lupus erythematosus: links and risks. Open Access Rheumatol (2019) 11:33&#x2013;45. doi:&#xa0;10.2147/OARRR.S167783</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/OARRR.S167783</ArticleId><ArticleId IdType="pmc">PMC6357904</ArticleId><ArticleId IdType="pubmed">30774485</ArticleId></ArticleIdList></Reference><Reference><Citation>Teruel M, Alarcon-Riquelme ME. Genetics of systemic lupus erythematosus and Sjogren&#x2019;s syndrome: an update. Curr Opin Rheumatol (2016) 28(5):506&#x2013;14. doi:&#xa0;10.1097/BOR.0000000000000310</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000310</ArticleId><ArticleId IdType="pubmed">27227345</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisetsky DS. Evolving story of autoantibodies in systemic lupus erythematosus. J Autoimmun (2020) 110:102356. doi:&#xa0;10.1016/j.jaut.2019.102356</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102356</ArticleId><ArticleId IdType="pmc">PMC8284812</ArticleId><ArticleId IdType="pubmed">31810857</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren&#x2019;s syndrome. Nat Rev Rheumatol (2013) 9(9):544&#x2013;56. doi:&#xa0;10.1038/nrrheum.2013.110</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.110</ArticleId><ArticleId IdType="pubmed">23857130</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Xie X, Zhang C, Su M, Gao S, Wang J, et al. . Rheumatoid arthritis, systemic lupus erythematosus and primary Sjogren&#x2019;s syndrome shared megakaryocyte expansion in peripheral blood. Ann Rheum Dis (2022) 81(3):379&#x2013;85. doi:&#xa0;10.1136/annrheumdis-2021-220066</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220066</ArticleId><ArticleId IdType="pmc">PMC8862024</ArticleId><ArticleId IdType="pubmed">34462261</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro-Dominguez D, Carmona-Saez P, Alarcon-Riquelme ME. Shared signatures between rheumatoid arthritis, systemic lupus erythematosus and Sjogren&#x2019;s syndrome uncovered through gene expression meta-analysis. Arthritis Res Ther (2014) 16(6):489. doi:&#xa0;10.1186/s13075-014-0489-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-014-0489-x</ArticleId><ArticleId IdType="pmc">PMC4295333</ArticleId><ArticleId IdType="pubmed">25466291</ArticleId></ArticleIdList></Reference><Reference><Citation>Imgenberg-Kreuz J, Sandling JK, Nordmark G. Epigenetic alterations in primary Sjogren&#x2019;s syndrome - an overview. Clin Immunol (2018) 196:12&#x2013;20. doi:&#xa0;10.1016/j.clim.2018.04.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2018.04.004</ArticleId><ArticleId IdType="pubmed">29649576</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhang K, Chen H, Sun F, Xu J, Wu Z, et al. . A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjogren&#x2019;s syndrome at 7q11.23. Nat Genet (2013) 45(11):1361&#x2013;5. doi:&#xa0;10.1038/ng.2779</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2779</ArticleId><ArticleId IdType="pubmed">24097066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nordmark G, Kristjansdottir G, Theander E, Eriksson P, Brun JG, Wang C, et al. . Additive effects of the major risk alleles of IRF5 and STAT4 in primary Sjogren&#x2019;s syndrome. Genes Immun (2009) 10(1):68&#x2013;76. doi:&#xa0;10.1038/gene.2008.94</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2008.94</ArticleId><ArticleId IdType="pubmed">19092842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Sun L, Zhang X. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases. J Autoimmun (2017) 83:31&#x2013;42. doi:&#xa0;10.1016/j.jaut.2017.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2017.03.009</ArticleId><ArticleId IdType="pubmed">28342734</ArticleId></ArticleIdList></Reference><Reference><Citation>Correa JD, Calderaro DC, Ferreira GA, Mendonca SM, Fernandes GR, Xiao E, et al. . Subgingival microbiota dysbiosis in systemic lupus erythematosus: association with periodontal status. Microbiome (2017) 5(1):34. doi:&#xa0;10.1186/s40168-017-0252-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0252-z</ArticleId><ArticleId IdType="pmc">PMC5359961</ArticleId><ArticleId IdType="pubmed">28320468</ArticleId></ArticleIdList></Reference><Reference><Citation>de Paiva CS, Jones DB, Stern ME, Bian F, Moore QL, Corbiere S, et al. . Altered mucosal microbiome diversity and disease severity in Sjogren syndrome. Sci Rep (2016) 6:23561. doi:&#xa0;10.1038/srep23561</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep23561</ArticleId><ArticleId IdType="pmc">PMC4834578</ArticleId><ArticleId IdType="pubmed">27087247</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Meulen TA, Harmsen HJM, Vila AV, Kurilshikov A, Liefers SC, Zhernakova A, et al. . Shared gut, but distinct oral microbiota composition in primary Sjogren&#x2019;s syndrome and systemic lupus erythematosus. J Autoimmun (2019) 97:77&#x2013;87. doi:&#xa0;10.1016/j.jaut.2018.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.009</ArticleId><ArticleId IdType="pubmed">30416033</ArticleId></ArticleIdList></Reference><Reference><Citation>Crow MK. Type I interferon in the pathogenesis of lupus. J Immunol (2014) 192(12):5459&#x2013;68. doi:&#xa0;10.4049/jimmunol.1002795</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002795</ArticleId><ArticleId IdType="pmc">PMC4083591</ArticleId><ArticleId IdType="pubmed">24907379</ArticleId></ArticleIdList></Reference><Reference><Citation>Nezos A, Gravani F, Tassidou A, Kapsogeorgou EK, Voulgarelis M, Koutsilieris M, et al. . Type I and II interferon signatures in Sjogren&#x2019;s syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren&#x2019;s related lymphomagenesis. J Autoimmun (2015) 63:47&#x2013;58. doi:&#xa0;10.1016/j.jaut.2015.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2015.07.002</ArticleId><ArticleId IdType="pmc">PMC4564326</ArticleId><ArticleId IdType="pubmed">26183766</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorlacius GE, Wahren-Herlenius M, Ronnblom L. An update on the role of type I interferons in systemic lupus erythematosus and Sjogren&#x2019;s syndrome. Curr Opin Rheumatol (2018) 30(5):471&#x2013;81. doi:&#xa0;10.1097/BOR.0000000000000524</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0000000000000524</ArticleId><ArticleId IdType="pubmed">29889694</ArticleId></ArticleIdList></Reference><Reference><Citation>Imgenberg-Kreuz J, Rasmussen A, Sivils K, Nordmark G. Genetics and epigenetics in primary Sjogren&#x2019;s syndrome. Rheumatol (Oxford) (2021) 60(5):2085&#x2013;98. doi:&#xa0;10.1093/rheumatology/key330</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/key330</ArticleId><ArticleId IdType="pmc">PMC8121440</ArticleId><ArticleId IdType="pubmed">30770922</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanata CM, Chung SA, Criswell LA. DNA methylation 101: what is important to know about DNA methylation and its role in SLE risk and disease heterogeneity. Lupus Sci Med (2018) 5(1):e000285. doi:&#xa0;10.1136/lupus-2018-000285</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2018-000285</ArticleId><ArticleId IdType="pmc">PMC6069928</ArticleId><ArticleId IdType="pubmed">30094041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzone R, Zwergel C, Artico M, Taurone S, Ralli M, Greco A, et al. . The emerging role of epigenetics in human autoimmune disorders. Clin Epigenet (2019) 11(1):34. doi:&#xa0;10.1186/s13148-019-0632-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13148-019-0632-2</ArticleId><ArticleId IdType="pmc">PMC6390373</ArticleId><ArticleId IdType="pubmed">30808407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao M, Zhang C, Gao C, Wang Q, Dai M, Yue R, et al. . Exploration of the shared gene signatures and molecular mechanisms between systemic lupus erythematosus and pulmonary arterial hypertension: evidence from transcriptome data. Front Immunol (2021) 12:658341. doi:&#xa0;10.3389/fimmu.2021.658341</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.658341</ArticleId><ArticleId IdType="pmc">PMC8320323</ArticleId><ArticleId IdType="pubmed">34335565</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WP, Maciuca R, Wolslegel K, Tew W, Abbas AR, Chaivorapol C, et al. . Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE. Lupus Sci Med (2015) 2(1):e000080. doi:&#xa0;10.1136/lupus-2014-000080</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000080</ArticleId><ArticleId IdType="pmc">PMC4379884</ArticleId><ArticleId IdType="pubmed">25861459</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Mi W, Luo H, Chen T, Liu S, Raman I, et al. . Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus. Arthritis Res Ther (2016) 18(1):162. doi:&#xa0;10.1186/s13075-016-1050-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-016-1050-x</ArticleId><ArticleId IdType="pmc">PMC4942934</ArticleId><ArticleId IdType="pubmed">27412348</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehar-Belaid D, Hong S, Marches R, Chen G, Bolisetty M, Baisch J, et al. . Mapping systemic lupus erythematosus heterogeneity at the single-cell level. Nat Immunol (2020) 21(9):1094&#x2013;106. doi:&#xa0;10.1038/s41590-020-0743-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0743-0</ArticleId><ArticleId IdType="pmc">PMC7442743</ArticleId><ArticleId IdType="pubmed">32747814</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasaki S, Suzuki K, Nishikawa A, Kassai Y, Takiguchi M, Kurisu R, et al. . Multiomic disease signatures converge to cytotoxic CD8 T cells in primary Sj&#xf6;gren&#x2019;s syndrome. Ann Rheumatic Dis (2017) 76(8):1458&#x2013;66. doi:&#xa0;10.1136/annrheumdis-2016-210788</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2016-210788</ArticleId><ArticleId IdType="pmc">PMC5738597</ArticleId><ArticleId IdType="pubmed">28522454</ArticleId></ArticleIdList></Reference><Reference><Citation>Sj&#xf6;strand M, Ambrosi A, Brauner S, Sullivan J, Malin S, Kuchroo VK, et al. . Expression of the immune regulator Tripartite-motif 21 is controlled by IFN regulatory factors. J Immunol (2013) 191(7):3753&#x2013;63. doi:&#xa0;10.4049/jimmunol.1202341</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1202341</ArticleId><ArticleId IdType="pubmed">23975864</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong X, Meng S, Tang D, Wang T, Ding L, Yu H, et al. . Single-cell RNA sequencing reveals the expansion of cytotoxic CD4+ T lymphocytes and a landscape of immune cells in Primary Sj&#xf6;gren&#x2019;s syndrome. Front Immunol (2021) 11:594658. doi:&#xa0;10.3389/fimmu.2020.594658</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.594658</ArticleId><ArticleId IdType="pmc">PMC7884617</ArticleId><ArticleId IdType="pubmed">33603736</ArticleId></ArticleIdList></Reference><Reference><Citation>Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinf (2008) 9:559. doi:&#xa0;10.1186/1471-2105-9-559</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-9-559</ArticleId><ArticleId IdType="pmc">PMC2631488</ArticleId><ArticleId IdType="pubmed">19114008</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. . limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res (2015) 43(7):e47. doi:&#xa0;10.1093/nar/gkv007</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkv007</ArticleId><ArticleId IdType="pmc">PMC4402510</ArticleId><ArticleId IdType="pubmed">25605792</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Y, Zhang T, Cai J, Huang C, Zhan S, Liu J. Bioinformatics and systems biology approach to identify the pathogenetic link of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front Immunol (2022) 13:952987. doi:&#xa0;10.3389/fimmu.2022.952987</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="pubmed">36189286</ArticleId></ArticleIdList></Reference><Reference><Citation>The Gene Ontology C. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res (2017) 45(D1):D331&#x2013;D8. doi:&#xa0;10.1093/nar/gkw1108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw1108</ArticleId><ArticleId IdType="pmc">PMC5210579</ArticleId><ArticleId IdType="pubmed">27899567</ArticleId></ArticleIdList></Reference><Reference><Citation>Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst (2015) 1(6):417&#x2013;25. doi:&#xa0;10.1016/j.cels.2015.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2015.12.004</ArticleId><ArticleId IdType="pmc">PMC4707969</ArticleId><ArticleId IdType="pubmed">26771021</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, et al. . STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res (2013) 41(Database issue):D808&#x2013;15. doi:&#xa0;10.1093/nar/gks1094</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks1094</ArticleId><ArticleId IdType="pmc">PMC3531103</ArticleId><ArticleId IdType="pubmed">23203871</ArticleId></ArticleIdList></Reference><Reference><Citation>Smoot ME, Ono K, Ruscheinski J, Wang PL, Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (2011) 27(3):431&#x2013;2. doi:&#xa0;10.1093/bioinformatics/btq675</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq675</ArticleId><ArticleId IdType="pmc">PMC3031041</ArticleId><ArticleId IdType="pubmed">21149340</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol (2014) 8 Suppl 4(Suppl 4):S11. doi:&#xa0;10.1186/1752-0509-8-S4-S11</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1752-0509-8-S4-S11</ArticleId><ArticleId IdType="pmc">PMC4290687</ArticleId><ArticleId IdType="pubmed">25521941</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo L, Ma C, Wang Z, Li J, He W, Niu W, et al. . Integrated bioinformatic analysis of the shared molecular mechanisms between osteoporosis and atherosclerosis. Front Endocrinol (Lausanne) (2022) 13:950030. doi:&#xa0;10.3389/fendo.2022.950030</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.950030</ArticleId><ArticleId IdType="pmc">PMC9353191</ArticleId><ArticleId IdType="pubmed">35937806</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira MR, Santos GA, Biagi CA, Silva Junior WA, Zambuzzi WF. GSVA score reveals molecular signatures from transcriptomes for biomaterials comparison. J BioMed Mater Res A (2021) 109(6):1004&#x2013;14. doi:&#xa0;10.1002/jbm.a.37090</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jbm.a.37090</ArticleId><ArticleId IdType="pubmed">32820608</ArticleId></ArticleIdList></Reference><Reference><Citation>Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM. 3rd, et&#xa0;al. Compr Integration Single-Cell Data Cell (2019) 177(7):1888&#x2013;902 e21. doi:&#xa0;10.1016/j.cell.2019.05.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.05.031</ArticleId><ArticleId IdType="pmc">PMC6687398</ArticleId><ArticleId IdType="pubmed">31178118</ArticleId></ArticleIdList></Reference><Reference><Citation>Aran D, Looney AP, Liu L, Wu E, Fong V, Hsu A, et al. . Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat Immunol (2019) 20(2):163&#x2013;72. doi:&#xa0;10.1038/s41590-018-0276-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-018-0276-y</ArticleId><ArticleId IdType="pmc">PMC6340744</ArticleId><ArticleId IdType="pubmed">30643263</ArticleId></ArticleIdList></Reference><Reference><Citation>Northcott M, Jones S, Koelmeyer R, Bonin J, Vincent F, Kandane-Rathnayake R, et al. . Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis. Lupus Sci Med (2022) 9(1):e000625. doi:&#xa0;10.1136/lupus-2021-000625</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2021-000625</ArticleId><ArticleId IdType="pmc">PMC8867321</ArticleId><ArticleId IdType="pubmed">35197305</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice GI, Forte GM, Szynkiewicz M, Chase DS, Aeby A, Abdel-Hamid MS, et al. . Assessment of interferon-related biomarkers in Aicardi-Goutieres syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study. Lancet Neurol (2013) 12(12):1159&#x2013;69. doi:&#xa0;10.1016/S1474-4422(13)70258-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(13)70258-8</ArticleId><ArticleId IdType="pmc">PMC4349523</ArticleId><ArticleId IdType="pubmed">24183309</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright HL, Thomas HB, Moots RJ, Edwards SW. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy. Rheumatol (Oxford) (2015) 54(1):188&#x2013;93. doi:&#xa0;10.1093/rheumatology/keu299</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keu299</ArticleId><ArticleId IdType="pubmed">25125592</ArticleId></ArticleIdList></Reference><Reference><Citation>Singhania A, Graham CM, Gabrysova L, Moreira-Teixeira L, Stavropoulos E, Pitt JM, et al. . Transcriptional profiling unveils type I and II interferon networks in blood and tissues across diseases. Nat Commun (2019) 10(1):2887. doi:&#xa0;10.1038/s41467-019-10601-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10601-6</ArticleId><ArticleId IdType="pmc">PMC6599044</ArticleId><ArticleId IdType="pubmed">31253760</ArticleId></ArticleIdList></Reference><Reference><Citation>Newman AM, Steen CB, Liu CL, Gentles AJ, Chaudhuri AA, Scherer F, et al. . Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat Biotechnol (2019) 37(7):773&#x2013;82. doi:&#xa0;10.1038/s41587-019-0114-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0114-2</ArticleId><ArticleId IdType="pmc">PMC6610714</ArticleId><ArticleId IdType="pubmed">31061481</ArticleId></ArticleIdList></Reference><Reference><Citation>Steen CB, Liu CL, Alizadeh AA, Newman AM. Profiling cell type abundance and expression in bulk tissues with CIBERSORTx. Methods Mol Biol (2020) 2117:135&#x2013;57. doi:&#xa0;10.1007/978-1-0716-0301-7_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-0716-0301-7_7</ArticleId><ArticleId IdType="pmc">PMC7695353</ArticleId><ArticleId IdType="pubmed">31960376</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. . Inference and analysis of cell-cell communication using CellChat. Nat Commun (2021) 12(1):1088. doi:&#xa0;10.1038/s41467-021-21246-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21246-9</ArticleId><ArticleId IdType="pmc">PMC7889871</ArticleId><ArticleId IdType="pubmed">33597522</ArticleId></ArticleIdList></Reference><Reference><Citation>Janky R, Verfaillie A, Imrichova H, Van de Sande B, Standaert L, Christiaens V, et al. . iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PloS Comput Biol (2014) 10(7):e1003731. doi:&#xa0;10.1371/journal.pcbi.1003731</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003731</ArticleId><ArticleId IdType="pmc">PMC4109854</ArticleId><ArticleId IdType="pubmed">25058159</ArticleId></ArticleIdList></Reference><Reference><Citation>Aibar S, Gonzalez-Blas CB, Moerman T, Huynh-Thu VA, Imrichova H, Hulselmans G, et al. . SCENIC: single-cell regulatory network inference and clustering. Nat Methods (2017) 14(11):1083&#x2013;6. doi:&#xa0;10.1038/nmeth.4463</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4463</ArticleId><ArticleId IdType="pmc">PMC5937676</ArticleId><ArticleId IdType="pubmed">28991892</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao R, Dong X, Gong J, Li Y, Guo X, Wang J, et al. . Single-cell RNA-sequencing and microarray analyses to explore the pathological mechanisms of chronic thromboembolic pulmonary hypertension. Front Cardiovasc Med (2022) 9:900353. doi:&#xa0;10.3389/fcvm.2022.900353</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2022.900353</ArticleId><ArticleId IdType="pmc">PMC9684175</ArticleId><ArticleId IdType="pubmed">36440052</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei J, Huang XJ, Huang Y, Xiong MY, Yao XY, Huang ZN, et al. . Key immune-related gene ITGB2 as a prognostic signature for acute myeloid leukemia. Ann Transl Med (2021) 9(17):1386. doi:&#xa0;10.21037/atm-21-3641</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm-21-3641</ArticleId><ArticleId IdType="pmc">PMC8506550</ArticleId><ArticleId IdType="pubmed">34733938</ArticleId></ArticleIdList></Reference><Reference><Citation>Manoussakis MN, Georgopoulou C, Zintzaras E, Spyropoulou M, Stavropoulou A, Skopouli FN, et al. . Sjogren&#x2019;s syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjogren&#x2019;s syndrome. Arthritis Rheum (2004) 50(3):882&#x2013;91. doi:&#xa0;10.1002/art.20093</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20093</ArticleId><ArticleId IdType="pubmed">15022331</ArticleId></ArticleIdList></Reference><Reference><Citation>Psarras A, Wittmann M, Vital EM. Emerging concepts of type I interferons in SLE pathogenesis and therapy. Nat Rev Rheumatol (2022) 18(10):575&#x2013;90. doi:&#xa0;10.1038/s41584-022-00826-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-022-00826-z</ArticleId><ArticleId IdType="pubmed">36097207</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez RK, Gordon MG, Subramaniam M, Kim MC, Hartoularos GC, Targ S, et al. . Single-cell RNA-seq reveals cell type-specific molecular and genetic associations to lupus. Science (2022) 376(6589):eabf1970. doi:&#xa0;10.1126/science.abf1970</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf1970</ArticleId><ArticleId IdType="pmc">PMC9297655</ArticleId><ArticleId IdType="pubmed">35389781</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 12(12):716&#x2013;30. doi:&#xa0;10.1038/nrrheum.2016.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin B, Ma N, Tang Q, Wei T, Yang M, Fu H, et al. . Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol (2016) 26(3):372&#x2013;6. doi:&#xa0;10.3109/14397595.2015.1091136</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/14397595.2015.1091136</ArticleId><ArticleId IdType="pubmed">26403379</ArticleId></ArticleIdList></Reference><Reference><Citation>Chapman EA, Lyon M, Simpson D, Mason D, Beynon RJ, Moots RJ, et al. . Caught in a trap? Proteomic analysis of neutrophil extracellular traps in rheumatoid arthritis and systemic lupus erythematosus. Front Immunol (2019) 10:423. doi:&#xa0;10.3389/fimmu.2019.00423</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00423</ArticleId><ArticleId IdType="pmc">PMC6421309</ArticleId><ArticleId IdType="pubmed">30915077</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng L, Chen Y, Liang T, Lin Y, Liu D, Yu C, et al. . Biomarkers of interstitial lung disease associated with primary Sjogren&#x2019;s syndrome. Eur J Med Res (2022) 27(1):199. doi:&#xa0;10.1186/s40001-022-00828-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-022-00828-3</ArticleId><ArticleId IdType="pmc">PMC9549683</ArticleId><ArticleId IdType="pubmed">36217184</ArticleId></ArticleIdList></Reference><Reference><Citation>Ittah M, Miceli-Richard C, Eric Gottenberg J, Lavie F, Lazure T, Ba N, et al. . B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren&#x2019;s syndrome. Arthritis Res Ther (2006) 8(2):R51. doi:&#xa0;10.1186/ar1912</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1912</ArticleId><ArticleId IdType="pmc">PMC1526588</ArticleId><ArticleId IdType="pubmed">16507175</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Lin J, Cao H, Xu D, Xu B, Xu L, et al. . Local and systemic IKKepsilon and NF-kappaB signaling associated with Sjogren&#x2019;s syndrome immunopathogenesis. J Immunol Res (2015) 2015:534648. doi:&#xa0;10.1155/2015/534648</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2015/534648</ArticleId><ArticleId IdType="pmc">PMC4563092</ArticleId><ArticleId IdType="pubmed">26380323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu H, Zheng J, Zhou Y, Wu T, Zhu T. Knockdown of RSAD2 attenuates B cell hyperactivity in patients with primary Sjogren&#x2019;s syndrome (pSS) via suppressing NF-kappab signaling pathway. Mol Cell Biochem (2021) 476(5):2029&#x2013;37. doi:&#xa0;10.1007/s11010-021-04070-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11010-021-04070-z</ArticleId><ArticleId IdType="pubmed">33512636</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Xu L, Su J, Peppelenbosch MP, Pan Q. Transcriptional regulation of antiviral interferon-stimulated genes. Trends Microbiol (2017) 25(7):573&#x2013;84. doi:&#xa0;10.1016/j.tim.2017.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2017.01.001</ArticleId><ArticleId IdType="pmc">PMC7127685</ArticleId><ArticleId IdType="pubmed">28139375</ArticleId></ArticleIdList></Reference><Reference><Citation>Park A, Iwasaki A. Type I and type III interferons - induction, signaling, evasion, and application to combat COVID-19. Cell Host Microbe (2020) 27(6):870&#x2013;8. doi:&#xa0;10.1016/j.chom.2020.05.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.008</ArticleId><ArticleId IdType="pmc">PMC7255347</ArticleId><ArticleId IdType="pubmed">32464097</ArticleId></ArticleIdList></Reference><Reference><Citation>Chenna Narendra S, Chalise JP, Biggs S, Kalinke U, Magnusson M. Regulatory T-cells mediate IFN-&#x3b1;-induced resistance against antigen-induced arthritis. Front Immunol (2018) 9:285. doi:&#xa0;10.3389/fimmu.2018.00285</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00285</ArticleId><ArticleId IdType="pmc">PMC5826073</ArticleId><ArticleId IdType="pubmed">29515584</ArticleId></ArticleIdList></Reference><Reference><Citation>Graalmann T, Borst K, Manchanda H, Vaas L, Bruhn M, Graalmann L, et al. . B cell depletion impairs vaccination-induced CD8+T cell responses in a type I interferon-dependent manner. Ann Rheumatic Dis (2021) 80(12):1537&#x2013;44. doi:&#xa0;10.1136/annrheumdis-2021-220435</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-220435</ArticleId><ArticleId IdType="pmc">PMC8600602</ArticleId><ArticleId IdType="pubmed">34226189</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo S, Wu R, Li Q, Zhang G. Epigenetic regulation of IFI44L expression in monocytes affects the functions of monocyte-derived dendritic cells in systemic lupus erythematosus. J Immunol Res (2022) 2022:4053038. doi:&#xa0;10.1155/2022/4053038</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/4053038</ArticleId><ArticleId IdType="pmc">PMC9113863</ArticleId><ArticleId IdType="pubmed">35592687</ArticleId></ArticleIdList></Reference><Reference><Citation>Nocturne G, Mariette X. B cells in the pathogenesis of primary Sjogren syndrome. Nat Rev Rheumatol (2018) 14(3):133&#x2013;45. doi:&#xa0;10.1038/nrrheum.2018.1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2018.1</ArticleId><ArticleId IdType="pubmed">29416129</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Duan SF, Gong YZ, Wang F, Chen XL. Identification of key genes associated with changes in the host response to severe burn shock: A bioinformatics analysis with data from the gene expression omnibus (GEO) database. J Inflammation Res (2020) 13:1029&#x2013;41. doi:&#xa0;10.2147/JIR.S282722</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S282722</ArticleId><ArticleId IdType="pmc">PMC7718973</ArticleId><ArticleId IdType="pubmed">33293847</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Cao C, Xie Z, Zhou Z. Analysis of potential hub genes involved in the pathogenesis of Chinese type 1 diabetic patients. Ann Transl Med (2020) 8(6):295. doi:&#xa0;10.21037/atm.2020.02.171</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/atm.2020.02.171</ArticleId><ArticleId IdType="pmc">PMC7186604</ArticleId><ArticleId IdType="pubmed">32355739</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara D, Carvajal P, Castro I, Barrera MJ, Aguilera S, Gonzalez S, et al. . Type I interferon dependent hsa-miR-145-5p downregulation modulates MUC1 and TLR4 overexpression in salivary glands from Sjogren&#x2019;s syndrome patients. Front Immunol (2021) 12:685837. doi:&#xa0;10.3389/fimmu.2021.685837</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.685837</ArticleId><ArticleId IdType="pmc">PMC8208490</ArticleId><ArticleId IdType="pubmed">34149728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Zhou Y, Zhu B, Wan M, Jiang T, Tan Q, et al. . IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann Rheum Dis (2016) 75(11):1998&#x2013;2006. doi:&#xa0;10.1136/annrheumdis-2015-208410</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-208410</ArticleId><ArticleId IdType="pmc">PMC4955646</ArticleId><ArticleId IdType="pubmed">26787370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Bogunovic D, Payelle-Brogard B, Francois-Newton V, Speer SD, Yuan C, et al. . Human intracellular ISG15 prevents interferon-alpha/beta over-amplification and auto-inflammation. Nature (2015) 517(7532):89&#x2013;93. doi:&#xa0;10.1038/nature13801</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature13801</ArticleId><ArticleId IdType="pmc">PMC4303590</ArticleId><ArticleId IdType="pubmed">25307056</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Ma H, Ye Z, Jing W, Jiang Z. Interferon-stimulated gene 15 expression in systemic lupus erythematosus: Diagnostic value and association with lymphocytopenia. Z Rheumatol (2018) 77(3):256&#x2013;62. doi:&#xa0;10.1007/s00393-017-0274-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00393-017-0274-8</ArticleId><ArticleId IdType="pubmed">28204879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashti N, Mahmoudi M, Gharibdoost F, Kavosi H, Rezaei R, Imeni V, et al. . Evaluation of ITGB2 (CD18) and SELL (CD62L) genes expression and methylation of ITGB2 promoter region in patients with systemic sclerosis. Rheumatol Int (2018) 38(3):489&#x2013;98. doi:&#xa0;10.1007/s00296-017-3915-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-017-3915-y</ArticleId><ArticleId IdType="pubmed">29356883</ArticleId></ArticleIdList></Reference><Reference><Citation>Slack RJ, Macdonald SJF, Roper JA, Jenkins RG, Hatley RJD. Emerging therapeutic opportunities for integrin inhibitors. Nat Rev Drug Discovery (2022) 21(1):60&#x2013;78. doi:&#xa0;10.1038/s41573-021-00284-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-021-00284-4</ArticleId><ArticleId IdType="pmc">PMC8446727</ArticleId><ArticleId IdType="pubmed">34535788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghilardi N, Pappu R, Arron JR, Chan AC. 30 years of biotherapeutics development-what have we learned? Annu Rev Immunol (2020) 38:249&#x2013;87. doi:&#xa0;10.1146/annurev-immunol-101619-031510</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-101619-031510</ArticleId><ArticleId IdType="pubmed">32340579</ArticleId></ArticleIdList></Reference><Reference><Citation>Behera R, Kumar V, Lohite K, Karnik S, Kundu GC. Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis (2010) 31(2):192&#x2013;200. doi:&#xa0;10.1093/carcin/bgp289</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/carcin/bgp289</ArticleId><ArticleId IdType="pubmed">19926637</ArticleId></ArticleIdList></Reference><Reference><Citation>Mastrangeli R, D&#x2019;Amici F, D&#x2019;Acunto CW, Fiumi S, Rossi M, Terlizzese M, et al. . A deamidated interferon-beta variant binds to integrin alphavbeta3. Cytokine (2018) 104:38&#x2013;41. doi:&#xa0;10.1016/j.cyto.2018.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2018.01.024</ArticleId><ArticleId IdType="pubmed">29414325</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker KF, Isaacs JD. Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn&#x2019;s disease and ulcerative colitis? Ann Rheum Dis (2018) 77(2):175&#x2013;87. doi:&#xa0;10.1136/annrheumdis-2017-211555</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-211555</ArticleId><ArticleId IdType="pubmed">28765121</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakou M, Bertsias G, Stagakis I, Centola M, Tassiulas I, Hatziapostolou M, et al. . Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PloS One (2010) 5(10):e13351. doi:&#xa0;10.1371/journal.pone.0013351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013351</ArticleId><ArticleId IdType="pmc">PMC2954787</ArticleId><ArticleId IdType="pubmed">20976278</ArticleId></ArticleIdList></Reference><Reference><Citation>Feagan BG, Rutgeerts P, Sands BE, Hanauer S, Colombel JF, Sandborn WJ, et al. . Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med (2013) 369(8):699&#x2013;710. doi:&#xa0;10.1056/NEJMoa1215734</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1215734</ArticleId><ArticleId IdType="pubmed">23964932</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandborn WJ, Feagan BG, Rutgeerts P, Hanauer S, Colombel JF, Sands BE, et al. . Vedolizumab as induction and maintenance therapy for Crohn&#x2019;s disease. N Engl J Med (2013) 369(8):711&#x2013;21. doi:&#xa0;10.1056/NEJMoa1215739</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1215739</ArticleId><ArticleId IdType="pubmed">23964933</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber SL, Benson V, Buckway CJ, Gonzales JM, Romanet D, Scholes B. Lifitegrast: a novel drug for patients with dry eye disease. Ther Adv Ophthalmol (2019) 11:2515841419870366. doi:&#xa0;10.1177/2515841419870366</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2515841419870366</ArticleId><ArticleId IdType="pmc">PMC6710705</ArticleId><ArticleId IdType="pubmed">31489402</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitroulis I, Alexaki VI, Kourtzelis I, Ziogas A, Hajishengallis G, Chavakis T. Leukocyte integrins: role in leukocyte recruitment and as therapeutic targets in inflammatory disease. Pharmacol Ther (2015) 147:123&#x2013;35. doi:&#xa0;10.1016/j.pharmthera.2014.11.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2014.11.008</ArticleId><ArticleId IdType="pmc">PMC4324083</ArticleId><ArticleId IdType="pubmed">25448040</ArticleId></ArticleIdList></Reference><Reference><Citation>Mogensen TH. IRF and STAT transcription factors - from basic biology to roles in infection, protective immunity, and primary immunodeficiencies. Front Immunol (2018) 9:3047. doi:&#xa0;10.3389/fimmu.2018.03047</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03047</ArticleId><ArticleId IdType="pmc">PMC6331453</ArticleId><ArticleId IdType="pubmed">30671054</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanitis E, Decker T. Regulatory networks involving STATs, IRFs, and NFkappaB in inflammation. Front Immunol (2018) 9:2542. doi:&#xa0;10.3389/fimmu.2018.02542</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02542</ArticleId><ArticleId IdType="pmc">PMC6242948</ArticleId><ArticleId IdType="pubmed">30483250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wack A, Terczynska-Dyla E, Hartmann R. Guarding the frontiers: the biology of type III interferons. Nat Immunol (2015) 16(8):802&#x2013;9. doi:&#xa0;10.1038/ni.3212</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3212</ArticleId><ArticleId IdType="pmc">PMC7096991</ArticleId><ArticleId IdType="pubmed">26194286</ArticleId></ArticleIdList></Reference><Reference><Citation>Platanias LC. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol (2005) 5(5):375&#x2013;86. doi:&#xa0;10.1038/nri1604</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri1604</ArticleId><ArticleId IdType="pubmed">15864272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ivashkiv LB, Donlin LT. Regulation of type I interferon responses. Nat Rev Immunol (2014) 14(1):36&#x2013;49. doi:&#xa0;10.1038/nri3581</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3581</ArticleId><ArticleId IdType="pmc">PMC4084561</ArticleId><ArticleId IdType="pubmed">24362405</ArticleId></ArticleIdList></Reference><Reference><Citation>Aue A, Szelinski F, Weissenberg SY, Wiedemann A, Rose T, Lino AC, et al. . Elevated STAT1 expression but not phosphorylation in lupus B cells correlates with disease activity and increased plasmablast susceptibility. Rheumatol (Oxford) (2020) 59(11):3435&#x2013;42. doi:&#xa0;10.1093/rheumatology/keaa187</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keaa187</ArticleId><ArticleId IdType="pubmed">32357246</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Li M, Qiao L, Wu C, Xu D, Zhao Y, et al. . Role of JAK-STAT signaling pathway in pathogenesis and treatment of primary Sjogren&#x2019;s syndrome. Chin Med J (Engl) (2023). doi:&#xa0;10.1097/CM9.0000000000002539</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000002539</ArticleId><ArticleId IdType="pubmed">37185152</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S, Biehl A, Gadina M, Hasni S, Schwartz DM. JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects. Drugs (2017) 77(5):521&#x2013;46. doi:&#xa0;10.1007/s40265-017-0701-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40265-017-0701-9</ArticleId><ArticleId IdType="pmc">PMC7102286</ArticleId><ArticleId IdType="pubmed">28255960</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Lee J, Kwok SK, Baek S, Jang SG, Hong SM, et al. . JAK-1 inhibition suppresses interferon-induced BAFF production in human salivary gland: potential therapeutic strategy for primary Sjogren&#x2019;s syndrome. Arthritis Rheumatol (2018) 70(12):2057&#x2013;66. doi:&#xa0;10.1002/art.40589</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.40589</ArticleId><ArticleId IdType="pubmed">29927095</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiang HS, Liu HM. The molecular basis of viral inhibition of IRF- and STAT-dependent immune responses. Front Immunol (2018) 9:3086. doi:&#xa0;10.3389/fimmu.2018.03086</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03086</ArticleId><ArticleId IdType="pmc">PMC6332930</ArticleId><ArticleId IdType="pubmed">30671058</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikushima H, Negishi H, Taniguchi T. The IRF family transcription factors at the interface of innate and adaptive immune responses. Cold Spring Harb Symp Quant Biol (2013) 78:105&#x2013;16. doi:&#xa0;10.1101/sqb.2013.78.020321</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/sqb.2013.78.020321</ArticleId><ArticleId IdType="pubmed">24092468</ArticleId></ArticleIdList></Reference><Reference><Citation>Honda K, Takaoka A, Taniguchi T. Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors. Immunity (2006) 25(3):349&#x2013;60. doi:&#xa0;10.1016/j.immuni.2006.08.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.08.009</ArticleId><ArticleId IdType="pubmed">16979567</ArticleId></ArticleIdList></Reference><Reference><Citation>Au WC, Moore PA, LaFleur DW, Tombal B, Pitha PM. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J Biol Chem (1998) 273(44):29210&#x2013;7. doi:&#xa0;10.1074/jbc.273.44.29210</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.273.44.29210</ArticleId><ArticleId IdType="pubmed">9786932</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Chen ZJ. Innate immune sensing and signaling of cytosolic nucleic acids. Annu Rev Immunol (2014) 32:461&#x2013;88. doi:&#xa0;10.1146/annurev-immunol-032713-120156</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-032713-120156</ArticleId><ArticleId IdType="pubmed">24655297</ArticleId></ArticleIdList></Reference><Reference><Citation>Jefferies CA. Regulating IRFs in IFN driven disease. Front Immunol (2019) 10:325. doi:&#xa0;10.3389/fimmu.2019.00325</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00325</ArticleId><ArticleId IdType="pmc">PMC6449421</ArticleId><ArticleId IdType="pubmed">30984161</ArticleId></ArticleIdList></Reference><Reference><Citation>Riviere E, Pascaud J, Tchitchek N, Boudaoud S, Paoletti A, Ly B, et al. . Salivary gland epithelial cells from patients with Sjogren&#x2019;s syndrome induce B-lymphocyte survival and activation. Ann Rheum Dis (2020) 79(11):1468&#x2013;77. doi:&#xa0;10.1136/annrheumdis-2019-216588</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-216588</ArticleId><ArticleId IdType="pubmed">32843324</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>